Skip to content
Question

Q.Insulin in the human body is secreted by pancreas as prohormone/proinsulin. The schematic polypeptide structure of proinsulin is given below. This proinsulin needs to undergo processing before it becomes functional in the body. Answer the questions that follow :

(a) State the change the proinsulin undergoes at the time of its processing to become functional.
(b) Name the technique the American company Eli Lilly used for the commercial production of human insulin.
(c) How are the two polypeptides of a functional insulin chemically held together ?
CBSECBSE Class XII Board 2020Subjective· 3mImportance★★★★★
🔒 Locked · start free trial →

You're viewing a preview — the full solution, concept, methods & PYQ mapping are locked.

Start your 14-day free trial to unlock the full solution →

Proinsulin is processed by removing the C-peptide to yield the active insulin molecule, which consists of two polypeptide chains (A and B) linked by disulfide bonds. Eli Lilly used recombinant DNA technology to produce human insulin commercially.

The Concept: Why Proinsulin Needs Processing

Insulin is a peptide hormone that regulates blood glucose levels. It is initially synthesised as a single, longer polypeptide chain called proinsulin — an inactive precursor (prohormone). This proinsulin has three segments: an A chain, a B chain, and a connecting C-peptide (the middle portion). The C-peptide keeps the A and B chains aligned correctly during folding, but it must be removed for the molecule to become biologically active. Without this cleavage, the insulin cannot bind properly to its receptor.

The processing is a classic example of post-translational modification — a common strategy in biology to prevent a potent molecule from acting prematurely inside the cell where it is made.


Step-by-Step Solution

(a) State the change the proinsulin undergoes at the time of its processing to become functional.

  1. Proinsulin is a single polypeptide chain with three regions: B chain (at the N-terminus), C-peptide (middle), and A chain (at the C-terminus). The C-peptide connects the B and A chains.

  2. During processing inside the pancreatic beta cells, specific proteolytic enzymes (prohormone convertases) cleave the proinsulin molecule at two sites — between the B chain and C-peptide, and between the C-peptide and A chain.

  3. The C-peptide is excised and removed, leaving two separate polypeptide chains: the B chain (30 amino acids) and the A chain (21 amino acids).

  4. These two chains remain associated through disulfide bonds (see part c), forming the mature, functional insulin molecule.

Watch out

A common mistake is to think that the C-peptide is part of the active insulin. It is not — it is a spacer that is discarded. The C-peptide has some biological activity of its own, but it is not required for insulin's glucose-lowering function.

Tip

The C-peptide is actually useful as a clinical marker: because it is released in equimolar amounts with insulin, measuring C-peptide levels helps distinguish between endogenous insulin production (e.g., in type 1 vs type 2 diabetes) and injected insulin.

Answer for (a): The proinsulin is cleaved to remove the C-peptide, yielding the separate A and B chains that form the active insulin.


(b) Name the technique the American company Eli Lilly used for the commercial production of human insulin.

  1. Before the 1980s, insulin for diabetic patients was extracted from the pancreases of pigs and cows (porcine and bovine insulin). These were slightly different from human insulin and could cause allergic reactions in some patients.

  2. Eli Lilly partnered with the biotech company Genentech to produce the first recombinant human insulin, approved in 1982 under the brand name Humulin.

  3. The technique used is recombinant DNA technology (also called genetic engineering). Specifically, they inserted the human insulin gene (or separately the A-chain and B-chain genes) into E. coli bacteria. The bacteria were then cultured in large fermentation tanks, where they expressed and produced the human insulin chains. These chains were purified and combined to form the active insulin.

Recombinant DNA technology = isolating a human gene → inserting it into a plasmid vector → transforming a host organism (e.g., E. coli or yeast) → culturing the host to produce the human protein → purifying the product. …

Unlock everything free for 14 days

  • Full step-by-step solutions
  • Concept-first explanations
  • Methods, shortcuts & mistakes
  • PYQ mapping + timed mock tests

Full access for 14 days. No credit card required.